ScholarIQanswers from OpenAlex & ORCID
Ulka N. Vaishampayan
ResearcherPublications, citations & collaboration network
Ulka N. Vaishampayan is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Ulka N. Vaishampayan have?
ScholarIQindexed works
Ulka N. Vaishampayan has 1,118 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Ulka N. Vaishampayan have?
ScholarIQcitation count
Ulka N. Vaishampayan has 25,857 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Ulka N. Vaishampayan?
ScholarIQh-index
Ulka N. Vaishampayan has an h-index of 75 in OpenAlex.
What is the i10-index of Ulka N. Vaishampayan?
ScholarIQi10-index
Ulka N. Vaishampayan has an i10-index of 316 in OpenAlex.
What is the ORCID of Ulka N. Vaishampayan?
ScholarIQorcid
The ORCID for Ulka N. Vaishampayan is on the source record.
What is the OpenAlex record for Ulka N. Vaishampayan?
ScholarIQopenalex
The OpenAlex for Ulka N. Vaishampayan is on the source record.
What are the most-cited papers on Ulka N. Vaishampayan?
ScholarIQmost cited works
Intermittent versus Continuous Androgen Deprivation in Prostate Cancer
Maha Hussain, Catherine M. Tangen, Donna L. Berry, Celestia S. Higano, E. David Crawford, Glenn Liu, George Wilding, Stephen M. Prescott, S.K. Sundaram, Eric J. Small, Nancy A. Dawson, Bryan Donnelly, Peter Venner, Ulka N. Vaishampayan, Paul F. Schellhammer, David I. Quinn, Derek Raghavan, Benjamin Ely, Carol M. Moinpour, Nicholas J. Vogelzang, Ian M. Thompson
Evaluation of BGJ398, a Fibroblast Growth Factor Receptor 1-3 Kinase Inhibitor, in Patients With Advanced Solid Tumors Harboring Genetic Alterations in Fibroblast Growth Factor Receptors: Results of a Global Phase I, Dose-Escalation and Dose-Expansion Study
Lucia Nogová, Lecia V. Sequist, José Manuel Pérez García, Fabrice André, Jean‐Pierre Delord, Manuel Hidalgo, Jan H.M. Schellens, Philippe A. Cassier, D. Ross Camidge, Martin Schüler, Ulka N. Vaishampayan, Howard A. Burris, Guangming Tian, Mario Campone, Zev A. Wainberg, Wan‐Teck Lim, Patricia LoRusso, Geoffrey I. Shapiro, Katie Parker, Xueying Chen, Somesh Choudhury, François Ringeisen, Diana Graus-Porta, Dale Porter, Randi Isaacs, Reinhard Buettner, Jürgen Wolf
The International Metastatic Renal Cell Carcinoma Database Consortium model as a prognostic tool in patients with metastatic renal cell carcinoma previously treated with first-line targeted therapy: a population-based study
Jenny J. Ko, Wanling Xie, Nils Kroeger, Jae-lyun Lee, Brian I. Rini, Jennifer J. Knox, Georg A. Bjarnason, Sandy Srinivas, Sumanta K. Pal, Takeshi Yuasa, Martin Smoragiewicz, Frede Donskov, Ravindran Kanesvaran, Lori Wood, D. Scott Ernst, Neeraj Agarwal, Ulka N. Vaishampayan, Sun Young Rha, Toni K. Choueiri, Daniel Y.C. Heng